Penumbra (PEN) Non-Current Assets (2014 - 2026)
Penumbra (PEN) reported Non-Current Assets of $623.0 million for Q1 2026, up 4.96% year-over-year from $593.6 million in Q1 2025, and up 2.16% quarter-over-quarter from $609.8 million in Q4 2025.
Penumbra (PEN) Non-Current Assets (2014 - 2026) Analysis & Trends
Penumbra (PEN) has 13 years of Non-Current Assets data on file, last reported at $623.0 million in Q1 2026.
- Non-Current Assets for Q1 2026 came in at $623.0 million, up 4.96% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.4 billion (up 3.88% YoY), and the FY2025 annual result was $609.8 million, up 4.77% from the prior year.
- Non-Current Assets advanced to $623.0 million in Q1 2026 per PEN's latest filing, from $609.8 million in the prior quarter.
- Over five years, Non-Current Assets peaked at $644.8 million in Q1 2024 and troughed at $582.1 million in Q4 2024.
- A 5-year average of $607.8 million and a median of $608.8 million in 2023 frame the typical range for Non-Current Assets.
- The sharpest annual moves came in 2022 and 2024: Non-Current Assets surged 197.16% in 2022, then retreated 9.18% in 2024.
- A 5-year view of Non-Current Assets shows it stood at $615.2 million in 2022, then climbed by 4.18% to $640.9 million in 2023, then retreated by 9.18% to $582.1 million in 2024, then climbed by 4.77% to $609.8 million in 2025, then grew by 2.16% to $623.0 million in 2026.
- Business Quant data shows PEN's Non-Current Assets at $623.0 million in Q1 2026, $609.8 million in Q4 2025, and $602.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 84.92 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 32.95 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 67.41 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 35.67 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 7.09 Bn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 26.70 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 20.47 Bn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 2.30 Bn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 8.34 Bn |
| 10 | Penumbra | 12.51 Bn | 11.90 Bn | 253.41 Mn | 623.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 623.03 Mn |
| Dec 31, 2025 | 609.84 Mn |
| Sep 30, 2025 | 602.85 Mn |
| Jun 30, 2025 | 609.33 Mn |
| Mar 31, 2025 | 593.60 Mn |
| Dec 31, 2024 | 582.06 Mn |
| Sep 30, 2024 | 587.37 Mn |
| Jun 30, 2024 | 590.77 Mn |
| Mar 31, 2024 | 644.82 Mn |
| Dec 31, 2023 | 640.90 Mn |
| Sep 30, 2023 | 599.90 Mn |
| Jun 30, 2023 | 604.66 Mn |
| Mar 31, 2023 | 608.81 Mn |
| Dec 31, 2022 | 615.19 Mn |
| Sep 30, 2022 | 597.98 Mn |
| Jun 30, 2022 | 609.94 Mn |
| Mar 31, 2022 | 611.25 Mn |
| Dec 31, 2021 | 562.78 Mn |
| Sep 30, 2021 | 305.25 Mn |
| Mar 31, 2021 | 205.70 Mn |